EZZ Life Science Holdings Balance Sheet Health
Financial Health criteria checks 6/6
EZZ Life Science Holdings has a total shareholder equity of A$21.3M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$25.6M and A$4.2M respectively. EZZ Life Science Holdings's EBIT is A$9.7M making its interest coverage ratio -56.8. It has cash and short-term investments of A$19.6M.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | -56.8x |
Cash | AU$19.58m |
Equity | AU$21.32m |
Total liabilities | AU$4.23m |
Total assets | AU$25.55m |
Recent financial health updates
No updates
Recent updates
EZZ Life Science Holdings Limited (ASX:EZZ) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Nov 04EZZ Life Science Holdings Limited's (ASX:EZZ) Shares Leap 41% Yet They're Still Not Telling The Full Story
Aug 28EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Jun 05There's No Escaping EZZ Life Science Holdings Limited's (ASX:EZZ) Muted Earnings Despite A 28% Share Price Rise
Apr 02Here's Why We Think EZZ Life Science Holdings (ASX:EZZ) Is Well Worth Watching
Feb 09EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Is Matching Sentiment Around Its Earnings
Oct 18EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations
Mar 06Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)
Nov 22Financial Position Analysis
Short Term Liabilities: EZZ's short term assets (A$24.9M) exceed its short term liabilities (A$4.2M).
Long Term Liabilities: EZZ's short term assets (A$24.9M) exceed its long term liabilities (A$51.0K).
Debt to Equity History and Analysis
Debt Level: EZZ is debt free.
Reducing Debt: EZZ has not had any debt for past 5 years.
Debt Coverage: EZZ has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: EZZ has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 02:54 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EZZ Life Science Holdings Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | Lodge Partners Pty Ltd. |
Chris Kallos | MST Financial Services Pty Limited |